<DOC>
	<DOCNO>NCT01355835</DOCNO>
	<brief_summary>12 patient idiopathic Parkinson 's disease refractory gait disturbance best individual subthalamic nucleus stimulation dopaminergic medication include randomised double-blind cross-over two-armed clinical trial . The treatment consist two different stimulation setting use ( ) conventional stimulation subthalamic nucleus [ STNmono ] ( ii ) combine stimulation distant electrode contact locate subthalamic nucleus caudal border zone STN substantia nigra par reticulata [ STN+SNr ] .</brief_summary>
	<brief_title>Combined STN/SNr-DBS Treatment Refractory Gait Disorders Parkinson 's Disease</brief_title>
	<detailed_description>A composite 'axial score ' include major clinical anamnestic item gait , posture balance function UPDRSII ( item 13-15 ) UPDRS III ( item 27-31 ) constitute primary outcome measure . Secondary outcome measure include specify clinical anamnestic assessment freeze gait , balance , quality life , non-motor symptom , impulsivity , impulse control neuropsychiatric symptom . The aim present trial investigate efficacy safety combine stimulation subthalamic nigral electrode contact [ STN+SNr ] refractory hypokinetic gait disturbance compare [ STNmono ] ( active comparator ) . The result clarify , whether combine [ STN+SNr ] stimulation improve otherwise refractory gait disturbance PD .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Written inform consent Age : 18 80 year Idiopathic Parkinson 's disease ( accord `` British Brain Bank criterion '' ( Hughes , 1992 ) include genetic form therapy STNDBS ( ACTIVA pulse generator ) least six month surgery Optimized subthalamic stimulation study enrolment ( refer 'treatment ' section ) Gait disturbance refractory best individual STNDBS ( STNmono ) dopaminergic therapy : 'gait score ' best clinical [ MedOn/STNmono ] condition ≥ 12 Clinical imageguided ( facultatively electrophysiological ) confirmation ( ) one two rostral contact quadripolar electrode localize STN area , ( ii ) caudal contact border zone STN SNr . Dopaminergic medication constant least four week prior study enrolment Disease duration ≥ 5 year Cognitive impairment ( Mini Mental State Exam &lt; 25 ) Participation clinical trial within past three month enrolment study Suicidality , Psychosis Other severe pathological chronic condition might confound treatment effect interpretation data Pregnancy Acute adverse event stimulation contact caudal STN / SNr border interfere intend stimulation protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Parkinson 's disease</keyword>
	<keyword>gait</keyword>
	<keyword>deep brain stimulation</keyword>
	<keyword>substantia nigra par reticulata</keyword>
	<keyword>subthalamic nucleus</keyword>
</DOC>